CVS
CVS HEALTH CORPData as of 2026 Q2 (06-30) · 13F snapshot
Summary
CVS HEALTH CORP (CVS) is held as common stock by 11 tracked hedge-fund managers, with a combined reported value of ~$6.73B; the largest are Dodge & Cox, Ken Griffin, Andreas Halvorsen. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 new, 4 added, 5 trimmed. 20 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Mixed
Common-stock holders114 also report options
Congress trades20
Price$87.85vs quarter-end-15.08%
Sectors1
This quarter's moves
Top holderDodge & CoxNew2
Added4
Trimmed / sold5
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Andreas HalvorsenNew large stake
Value $378.97M1.1% of portfolio3,663,3612026 Q2
Value $23.38M0.6% of portfolio226,0362026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Andreas Halvorsen | $378.97M | 1.1% | New large stake |
| Davidson Kempner | $23.38M | 0.6% | Add |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $299.59M— of portfolio2,896,0002026 Q2
Value $267.08M— of portfolio2,581,7002026 Q2
Value $20.60M— of portfolio199,1002026 Q2
Value $16.91M— of portfolio163,5002026 Q2
Value $13.20M— of portfolio127,6002026 Q2
Value $5.61M— of portfolio54,2002026 Q2
Value $4.93M— of portfolio47,7002026 Q2
Value $3.51M— of portfolio33,9002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $299.59M | — | — |
| Ken GriffinPUT | $267.08M | — | — |
| Paul Tudor JonesCALL | $20.60M | — | — |
| Izzy EnglanderPUT | $16.91M | — | — |
| Paul Tudor JonesPUT | $13.20M | — | — |
| Izzy EnglanderCALL | $5.61M | — | — |
| Steven CohenCALL | $4.93M | — | — |
| Steven CohenPUT | $3.51M | — | — |
Insider Trading
Officers · directors · Form 4Open-market purchases and sales (P/S)8
Larry Robbins
Director
Sell$74.56M797,628 @ $93.48Traded 2026-05-19Filed 2026-05-21Larry Robbins
Director
Sell$14.4K151 @ $95.18Traded 2026-05-19Filed 2026-05-21Larry Robbins
Director
Sell$187.33M1,983,387 @ $94.45Traded 2026-05-19Filed 2026-05-21Larry Robbins
Director
Sell$77.0K800 @ $96.28Traded 2026-05-19Filed 2026-05-21Larry Robbins
Director
Sell$6.40M66,881 @ $95.67Traded 2026-05-19Filed 2026-05-21Larry Robbins
Director
Sell$14.48M152,691 @ $94.81Traded 2026-05-19Filed 2026-05-21Larry Robbins
Director
Sell$35.27M378,000 @ $58.29Traded 2026-05-19Filed 2026-05-21Larry Robbins
Director
Sell$34.62M370,462 @ $93.45Traded 2026-05-19Filed 2026-05-21
Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.